PMA P180002S004

Device
Zephyr Endobronchial Valve System
Applicant
Pulmonx Corporation
PMA number
P180002
Supplement
S004
Product code
NJK
Decision date
2019-01-28
Classification
Valve, Pulmonary
Generic name
Valve, pulmonary
Approval order statement
Approval for a waiver of the 6-month Post Approval Study (PAS) reporting requirement for the LIBERATE extension study.

Current openFDA PMA Record#

Device
Zephyr Endobronchial Valve System
Applicant
Pulmonx Corporation
PMA number
P180002
Supplement
S004
Product code
NJK
Generic name
Valve, pulmonary
Decision date
2019-01-28
Decision code
APPR
Date received
2018-11-29
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
Approval for a waiver of the 6-month Post Approval Study (PAS) reporting requirement for the LIBERATE extension study.